Sol-Gel

$6.33 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Sol-Gel

Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.

Stock Analysis

last close $6.45
1-mo return -10.3%
3-mo return -12.5%
avg daily vol. 17.36T
52-week high 14.5
52-week low 5.5
market cap. $143M
forward pe -
annual div. -
roe 6.1%
ltg forecast -
dividend yield -
annual rev. $31M
inst own. 14%
baraka

Subscribe now for daily local and international financial news

Subscribe